Ophthalmology · Wilmington, NC
NPI
1174842363
Since 2010
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1729 New Hanover Medical Park Dr
Wilmington, NC, 28403
Phone (910) 772-8261
Groups this clinician bills Medicare through
Medicare paid, 2024
$277K
3,299 services
Medicare patients, 2024
1,110
Average age 75
Drug cost, 2024
$169K
1,958 prescriptions
Company payments, 2025
$1,166
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Travis C Jenkins was code 99213 (office e&m - established), 826 times for 597 patients. In total Travis C Jenkins billed 3,299 services in 31 codes, and Medicare paid $277K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 826 | 597 | $53.44 | $44K |
| 99214 Office E&M - Established | Office | 441 | 414 | $89.44 | $39K |
| 92134 Computerized Ophthalmic Imaging | Office | 423 | 205 | $13.04 | $5,517 |
| 92133 Computerized Ophthalmic Imaging | Office | 365 | 168 | $11.07 | $4,039 |
| 66984 Cataract Surgery | Facility | 281 | 168 | $367.62 | $103K |
| 92136 Ultrasound - Nonspecific | Office | 234 | 213 | $32.92 | $7,703 |
| 92025 Test - Miscellaneous | Office | 214 | 194 | $23.96 | $5,128 |
| 99204 Office E&M - New | Office | 129 | 129 | $103.88 | $13K |
| 66821 Cataract Surgery | Facility | 104 | 82 | $226.21 | $24K |
| 92083 Vision, Hearing, and Speech Services | Office | 67 | 60 | $39.05 | $2,616 |
| 99212 Office E&M - Established | Office | 40 | 31 | $38.84 | $1,553 |
| 92014 Ophthalmological E&M | Office | 39 | 39 | $82.10 | $3,202 |
| 66982 Cataract Surgery | Facility | 23 | 17 | $495.19 | $11K |
| 99203 Office E&M - New | Office | 22 | 22 | $64.49 | $1,419 |
| 68761 Eye | Office | 17 | 13 | $144.43 | $2,455 |
By year: 2022 $276K for 2,582 services; 2023 $293K for 3,049 services; 2024 $277K for 3,299 services.
Medicare prescription drug claims, 2024
In 2024, the drug Travis C Jenkins prescribed most often to Medicare patients was Prednisolone Acetate, with 411 prescriptions and refills. In total Travis C Jenkins wrote 1,958 Medicare prescriptions that cost $169K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 411 | 477 | 225 | $12K |
| Moxifloxacin Moxifloxacin Hcl | 360 | 367 | 201 | $7,770 |
| Ketorolac Tromethamine Generic | 327 | 362 | 204 | $5,445 |
| Latanoprost Generic | 174 | 301 | 45 | $2,068 |
| Timolol Maleate Generic | 121 | 213 | 44 | $782 |
| Cyclopentolate Hcl Generic | 76 | 79 | 75 | $625 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 54 | 115 | 17 | $936 |
| Restasis Cyclosporine | 43 | 83 | 23 | $49K |
| Lumigan Bimatoprost | 39 | 61 | Under 11 | $14K |
| Fluorometholone Generic | 37 | 74 | 24 | $2,523 |
| Valacyclovir Valacyclovir Hcl | 34 | 66 | 14 | $1,119 |
| Dorzolamide Hcl Generic | 31 | 65 | 12 | $439 |
| Erythromycin Erythromycin Base | 25 | 25 | 16 | $203 |
| Brimonidine Tartrate Generic | 24 | 39 | Under 11 | $563 |
| Xiidra Lifitegrast | 22 | 42 | Under 11 | $28K |
Brand drugs: 698 claims; generic drugs: 1,260 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Travis C Jenkins $1,166 ($1,166 in general payments such as food, travel and fees) from 6 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $472.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 12 | $472 |
| Alcon Vision LLC ALC | 5 | $199 |
| Harrow Eye, LLC | 5 | $146 |
| Bausch & Lomb Americas Inc. BLCO | 7 | $126 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $115 |
| Medline Industries LP | 1 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.